Targeting glutamine metabolism in multiple myeloma enhances BIM binding to BCL-2 eliciting synthetic lethality to venetoclax - Concepedia

Concepedia

Publication | Open Access

Targeting glutamine metabolism in multiple myeloma enhances BIM binding to BCL-2 eliciting synthetic lethality to venetoclax

DOI Full Paper Access

98

Citations

44

References

2015

Year

Richa Bajpai, Shannon M. Matulis, Changyong Wei, A K Nooka, H E Von Hollen, Sagar Lonial, Lawrence Boise, Muthu K. Shanmugam

Hematological MalignancyGlutamine MetabolismMedicineMalignant Blood DisorderImmunologySynthetic LethalityCell DeathImmune Checkpoint InhibitorAnti-cancer AgentImmunotherapyPharmacologyCell BiologyMyeloid Neoplasia

References

	Year	Citations

Page 1

Page 1